Breaking News: JPML Transfers All Federal Prescription Testosterone Lawsuits to the Northern District of Illinois for Low-T MDL

The Judicial Panel on Multidistrict Litigation just issued it’s order transferring all federal prescription testosterone injury lawsuits for consolidated pre-trial proceedings in the Northern District of Illinois. Although at least one manufacturer objected to an industry-wide consolidation, the panel correctly concluded that consolidation of lawsuits involving all prescription testosterone products is the most effective way of managing the litigation to its resolution. We believe this consolidation is the first step towards ensuring compensation for the thousands of men who suffered heart attacks, stroke, pulmonary and death caused by prescription testosterone products such as AndroGel, Testim, Axiron and Fortesta. The JPML’s order can be found at the following link: http://www.jpml.uscourts.gov/sites/jpml/files/MDL-2545-Initial_Transfer-05-14.pdf

The Levensten Law Firm was at the forefront of exposing to the public the cardiovascular risks of testosterone products, like AndroGel, Testim, Axiron, and Fortesta, through our FOIA request to the FDA and other efforts. If you or a loved one suffered a heart attack, stroke, pulmonary embolism or death while taking a prescription testosterone product, please feel free to contact the Levensten Law Firm to learn how to protect your rights to compensation.